Adjuvant Global Health Technology Fund, L.P. An2 Therapeutics, Inc. (ANTX) insider trading activity
Adjuvant Global Health Technology Fund, L.P. is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 2 Million shares of ANTX, which is worth approximately $3.33 Million. The most recent transaction as insider was on Jan 16, 2024, when has been sold 84,093 shares (Common Stock) at a price of $19.65 per share, resulting in proceeds of $1,652,427. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2M
0%
3M change
4.04%
12M change
Total Value Held
$3.33 Million
Adjuvant Global Health Technology Fund, L.P. Transaction History
AGH
Adjuvant Global Health Technology Fund, L.P.
New York, NY